The struggling Danish company says it looks to reorganize, with the impact on North Carolina workers still unclear.

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it ...

The company downgraded its guidance for the second time in six weeks as it announced a restructuring plan.

Novo Nordisk will soon require its staff to work in the office full-time after it cut thousands of jobs. The Ozempic maker ...

Novo Nordisk - makers of Ozempic - is set to lay off 9,000 staff members, or 11.5 % of its workforce. Five thousand of the ...

Novo Nordisk, the Danish pharmaceutical company known for its weight-loss drug Wegovy and diabetes medicine Ozempic, has ...

At their heights, Denmark’s corporate champions seemed untouchable. Novo Nordisk A/S, long known mostly as an insulin maker, was Europe’s most valuable company last year, after riding a surge of ...

Novo, which has 78,400 positions globally, said about 5,000 of the job cuts will be in its native Denmark. Read more at ...

Novo Nordisk will cut 9,000 jobs, about 11.5% of its global workforce, as new CEO Maziar Mike Doustdar launches a major ...

The maker of the popular weight-loss drug Wegovy announced on Wednesday that it will be cutting 9,000 jobs in the company.

The Danish pharma giant outlined proposals to shed around 11% of its 78,400-strong workforce amid stiff competition from ...